16
Participants
Start Date
May 31, 2007
Primary Completion Date
January 31, 2010
Study Completion Date
February 28, 2010
GC1008
1 mg/kg, IV infusion on Day 0 and monitored over 24 hours. Post infusion for safety up to 112 days.
GC1008
2 mg/kg, IV infusion on Day 0 and monitored over 24 hours. Post infusion for safety up to 112 days.
GC1008
4 mg/kg, IV infusion on Day 0 and monitored over 24 hours. Post infusion for safety up to 112 days.
GC1008
0.3 mg/kg, IV infusion on Day 0 and monitored over 24 hours. Post infusion for safety up to 112 days.
San Francisco
Rochester
Chapel Hill
Berlin
Düsseldorf
Solingen
Bergamo
Cambridge
New Hyde Park
Genzyme, a Sanofi Company
INDUSTRY